TP53 polymorphism as a risk factor for hepatocellular carcinoma in hepatitis C virus-infected Egyptian patients
Conclusion This case–control analysis confirmed that the Pro/Pro (C/C) genotype and the Pro (C) allele of TP53 codon 72 are associated with increased risk of HCC in HCV-infected patients. Additionally, the data suggest that the plasma TP53 level is downregulated in HCC.
Source: Egyptian Journal of Basic and Applied Sciences - Category: Science Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Egypt Health | Genetics | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Science | Study | Urology & Nephrology